<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND AIM: To evaluate the expression of fatty acid synthase (FAS) in the <z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e>-<z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>-oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> sequence compared with p53 and Ki67 expressions, retained for a long time reliable markers of oesophageal cells biological behaviour </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: In <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, <z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e> and oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> patients, biopsies were taken from pathologic sites of the mucosa for histological and immuno-histochemical detection of FAS, p53 and Ki67 </plain></SENT>
<SENT sid="2" pm="."><plain>FAS expression was positive, when a strong granular cytoplasmic staining was observed in oesophageal cells </plain></SENT>
<SENT sid="3" pm="."><plain>Ki67 and p53 was defined positive, when nuclear staining was clearly detected at 10x magnification </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: A mild expression of FAS was found in 39% of patients with <z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The amount of FAS expression increased up to 70% in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> while this was present in <z:hpo ids='HP_0000001'>all</z:hpo> patients with oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (p = 0.0001) </plain></SENT>
<SENT sid="6" pm="."><plain>In <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, p53 was mildly or intensely expressed in 77% and in 15% of cases, respectively, and mildly or intensely expressed in 33% and 67% of patients with oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, respectively, (p = 0.0001) </plain></SENT>
<SENT sid="7" pm="."><plain>Ki67 was mildly expressed in 17% of <z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e> cases and was absent in the majority of cases </plain></SENT>
<SENT sid="8" pm="."><plain>In <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>, a mild Ki67 expression was present in 46% of cases, and in oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> it was present prevalently in intense form (67%; p = 0.0001) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: The over-expression of p53, Ki67 and FAS in otherwise similar morphological groups may be useful to stratify patients into selected prognostic subgroups in order to achieve better clinical approaches </plain></SENT>
</text></document>